17:24

Experts Discuss the State of Myelofibrosis Management

10:43

How Do Experts Proceed with CNS Lymphoma Consolidation Therapy, Follow-up?

8:30

What Do the Opening Steps in CNS Lymphoma Management Look Like Today?

57:56

ASH 2024 Lymphoma and CLL Highlights

6:00

MRD Negativity in Focus: Dr. Usmani on New CARTITUDE-4 Data

9:47

New Frontiers in Myelofibrosis Care Presented at ASH 2024

7:41

What is the Connection between Hemoglobin Levels and Quality of Life in MDS?

6:07

Optimizing MDS Management: Key Takeaways from the COMMANDS Trial